Vanda Pharmaceuticals Files 8-K
Ticker: VNDA · Form: 8-K · Filed: Jun 6, 2024 · CIK: 1347178
| Field | Detail |
|---|---|
| Company | Vanda Pharmaceuticals Inc. (VNDA) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, filing
Related Tickers: VNDA
TL;DR
Vanda Pharma dropped an 8-K, could be anything, check it out.
AI Summary
Vanda Pharmaceuticals Inc. filed an 8-K on June 6, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosure.
Why It Matters
This filing indicates that Vanda Pharmaceuticals is making a disclosure to the public, which could contain material information relevant to investors.
Risk Assessment
Risk Level: medium — The filing is a standard 8-K, but the lack of specific details about the disclosure makes it difficult to assess the immediate impact.
Key Players & Entities
- Vanda Pharmaceuticals Inc. (company) — Registrant
- June 6, 2024 (date) — Date of earliest event reported
- 20240606 (date) — Conformed Period of Report
- 2200 Pennsylvania Avenue NW Suite 300E Washington, DC 20037 (address) — Principal executive offices
- (202) 734-3400 (phone_number) — Registrant's telephone number
FAQ
What is the specific nature of the Regulation FD Disclosure?
The filing does not specify the details of the Regulation FD Disclosure, only that it is being made.
Are there any financial statements included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific statements are not detailed in the provided text.
What is Vanda Pharmaceuticals Inc.'s principal executive office address?
Vanda Pharmaceuticals Inc.'s principal executive offices are located at 2200 Pennsylvania Avenue NW Suite 300E Washington, DC 20037.
When was this 8-K form filed?
This 8-K form was filed on June 6, 2024.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 03-0491827.
Filing Stats: 564 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-06-06 16:30:57
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share VNDA The Nasdaq Global Ma
Filing Documents
- d824540d8k.htm (8-K) — 27KB
- d824540dex991.htm (EX-99.1) — 7KB
- g824540newlogo.jpg (GRAPHIC) — 17KB
- 0001193125-24-156117.txt ( ) — 217KB
- vnda-20240606.xsd (EX-101.SCH) — 4KB
- vnda-20240606_def.xml (EX-101.DEF) — 13KB
- vnda-20240606_lab.xml (EX-101.LAB) — 22KB
- vnda-20240606_pre.xml (EX-101.PRE) — 14KB
- d824540d8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Vanda Pharmaceuticals Inc. dated June 6, 2024, Confirming Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 6, 2024 VANDA PHARMACEUTICALS INC. By: /s/ Timothy Williams Name: Timothy Williams Title: Senior Vice President, General Counsel and Secretary